content: <HTML>
  <HEAD>
  <TITLE>sv8</TITLE>
  </HEAD>
  <BODY bgcolor="#FFFFFF">
  <!-- PAGEBREAK -->
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  
  <P align="center" style="font-size: 10pt"><B>As filed with the Securities and Exchange Commission on May&nbsp;13, 2005</B>
  
  
  
  <P align="right" style="font-size: 10pt"><B>Registration No.&nbsp;333-_____</B>
  
  
  
  <DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
  <DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>
  
  
  
  
  <P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
  SECURITIES AND EXCHANGE COMMISSION</B>
  
  <DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
  </DIV>
  
  
  <P align="center" style="font-size: 10pt"><HR size="1" noshade width="15%" align="center" color="#000000">
  
  
  <P align="center" style="font-size: 18pt"><B>FORM S-8</B>
  
  
  <P align="center" style="font-size: 12pt"><B>Registration Statement Under The Securities Act of 1933</B>
  
  
  
  <P align="center" style="font-size: 12pt"><HR size="1" noshade width="15%" align="center" color="#000000">
  
  
  
  <P align="center" style="font-size: 24pt"><B>CYBERKINETICS NEUROTECHNOLOGY SYSTEMS, INC.</B>
  
  
  <DIV align="center" style="font-size: 10pt"><B>(Exact name of registrant as specified in its charter)</B></DIV>
  
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="47%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="47%">&nbsp;</TD>
  </TR>
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD align="center" valign="top"><B>Delaware</B>
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top"><B>13-4287300</B></TD>
  </TR>
  <TR valign="bottom" style="font-size: 8pt">
      <TD align="center" valign="top"><B>(State or other jurisdiction of<BR>
  incorporation or organization)</B>
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top"><B>(I.R.S. Employer<BR>
  Identification No.)</B></TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <P align="center" style="font-size: 10pt"><B>100 Foxborough Blvd., Suite&nbsp;240<BR>
  Foxborough, MA 02035</B>
  <DIV align="center" style="font-size: 8pt"><B>(Address of principal
  executive offices)</B></DIV>
  
  
  
  <P align="center" style="font-size: 10pt"><B>(508)&nbsp;549-9981</B>
  <DIV align="center" style="font-size: 8pt"><B>(Registrant&#146;s
  telephone number, including area code)</B></DIV>
  
  
  
  <P align="center" style="font-size: 10pt"><HR size="1" noshade width="15%" align="center" color="#000000">
  
  
  
  <P align="center" style="font-size: 10pt"><B>Second Amended and Restated 2002 Equity Incentive Plan<BR>
  Second Amended and Restated Founders&#146; Option Plan</B>
  <DIV align="center" style="font-size: 8pt"><B>(Full Title of the
  plans)</B></DIV>
  
  
  
  <P align="center" style="font-size: 10pt"><HR size="1" noshade width="15%" align="center" color="#000000">
  
  
  
  <P align="center" style="font-size: 10pt"><B>Timothy R. Surgenor<BR>
  President and Chief Executive Officer<BR>
  100 Foxborough Blvd., Suite&nbsp;240<BR>
  Foxborough, MA 02035<BR>
  (508)&nbsp;549-9981</B>
  
  
  <DIV align="center" style="font-size: 8pt"><B>(Name, Address, and Telephone Number, Including Area Code, of Agent for Service)</B></DIV>
  
  
  
  <P align="center" style="font-size: 10pt"><I>Copies to:</I><BR>
  <B>Katherine J. Blair, Esq.<BR>
  Shoshannah D. Katz, Esq.<BR>
  Kirkpatrick &#038; Lockhart Nicholson Graham LLP<BR>
  10100 Santa Monica Boulevard, Seventh Floor<BR>
  Los Angeles, CA 90067<BR>
  Telephone: (310)&nbsp;552-5000<BR>
  Facsimile: (310)&nbsp;552-5001</B>
  
  
  
  <P align="center" style="font-size: 10pt"><HR size="1" noshade width="15%" align="center" color="#000000">
  
  
  
  <P align="center" style="font-size: 10pt"><B>CALCULATION OF REGISTRATION FEE</B>
  
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="1%">&nbsp;</TD>
      <TD width="59%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD><!-- VRule -->
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="8%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD><!-- VRule -->
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD><!-- VRule -->
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD><!-- VRule -->
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  
  <TR style="font-size: 1px" valign="bottom">
      <TD nowrap align="left" colspan="23" style="border-bottom: 3px solid #000000">&nbsp;</TD>
  </TR>
  
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD nowrap align="center"><B>Title of</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Proposed Maximum</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Proposed Maximum</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD nowrap align="center"><B>Securities to be</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Amount to be</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Offering Price</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Aggregate</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Amount of</B></TD>
      <TD>&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD nowrap align="center"><B>Registered</B></TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B>Registered</B><SUP style="font-size: 85%; vertical-align: text-top"><B>(1)</B></sup></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>per Share</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Offering Price</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 2px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Registration Fee</B></TD>
      <TD>&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                      <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock,
  $0.001 par value
  per share</DIV></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
  
  <TD nowrap colspan="3" align="right" style="border-top: 2px solid #000000">126,280 shares</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
  
  <TD nowrap align="left" style="border-top: 2px solid #000000">$</TD>
      <TD align="right" style="border-top: 2px solid #000000">1.55</TD>
      <TD nowrap style="border-top: 2px solid #000000"><SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
  
  <TD nowrap align="left" style="border-top: 2px solid #000000">$</TD>
      <TD align="right" style="border-top: 2px solid #000000">195,734</TD>
      <TD nowrap style="border-top: 2px solid #000000"><SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="left" style="border-top: 2px solid #000000">$</TD>
      <TD align="right" style="border-top: 2px solid #000000">23</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock,
  $0.001 par value
  per share</DIV></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD nowrap colspan="3" align="center" style="border-top: 2px solid #000000">3,413,150 shares</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 2px solid #000000">$</TD>
      <TD align="right" style="border-top: 2px solid #000000">0.50</TD>
      <TD nowrap style="border-top: 2px solid #000000"><SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 2px solid #000000">$</TD>
      <TD align="right" style="border-top: 2px solid #000000">1,706,575</TD>
      <TD nowrap style="border-top: 2px solid #000000"><SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="left" style="border-top: 2px solid #000000">$</TD>
      <TD align="right" style="border-top: 2px solid #000000">201</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
  
  <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Total:</DIV></TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
  
  <TD nowrap colspan="3" align="center" style="border-top: 2px solid #000000">3,539,430 shares</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="left" style="border-top: 2px solid #000000">$</TD>
      <TD align="right" style="border-top: 2px solid #000000">1,902,309</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD align="left" style="border-top: 2px solid #000000">$</TD>
      <TD align="right" style="border-top: 2px solid #000000">224</TD>
      <TD style="border-top: 2px solid #000000">&nbsp;</TD>
      <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
  </TR>
  <TR style="font-size: 1px" valign="bottom">
      <TD nowrap align="left" colspan="23" style="border-top: 3px solid #000000">&nbsp;</TD>
  </TR>
  
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <P>
  <HR size="1" width="18%" align="left" noshade color="#000000">
  
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top">
      <TD width="1%" nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(1)</SUP></TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="96%">Represents (i)&nbsp;126,280 shares of Common Stock available for issuance under
  the Registrant&#146;s Second Amended and Restated 2002 Equity
  Incentive Plan, (ii)&nbsp;2,344,735
  shares of Common Stock underlying outstanding stock options granted under the Registrant&#146;s
  Second Amended and Restated 2002 Equity Incentive Plan and
  (iii)&nbsp;1,068,415 shares of Common
  Stock underlying stock options granted under the Registrant&#146;s Second Amended and Restated
  Founders&#146; Option Plan. This Registration Statement also covers an indeterminate number of
  shares of Common Stock which may be issuable by reason of stock splits, stock dividends or
  similar transactions pursuant to Rule&nbsp;416 of the Securities Act of 1933, as amended (the
  &#147;Securities Act&#148;).</TD>
  </TR>
  
  <TR><TD>&nbsp;</TD></TR>
  
  <TR valign="top">
      <TD width="1%" nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP></TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="96%">Estimated in accordance with Rule 457(c) and (h)&nbsp;under the Securities Act, solely
  for the purpose of calculating the total registration fee. Computation based upon the
  average of the high ($1.65) and low ($1.45) prices of the Common Stock as reported on the
  Over-the-Counter Bulletin Board on May&nbsp;11, 2005.</TD>
  </TR>
  
  <TR><TD>&nbsp;</TD></TR>
  
  <TR valign="top">
      <TD width="1%" nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="96%">Calculated solely for purposes of this offering under Rule 457(h) of the
  Securities Act on the basis of the weighted average exercise price of the outstanding
  options.</TD>
  </TR>
  
  </TABLE>
  
  
  
  <DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
  <DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
  
  
  
  
  
  <P align="center" style="font-size: 10pt">&nbsp;
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <!-- TOC -->
  <A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>
  
  <P><CENTER>
  <TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
  <TR>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="76%"></TD>
  </TR>
  <TR><TD colspan="9"><A HREF="#000">PART I<BR> INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;1. Plan Information</A></TD></TR>
  <TR><TD colspan="9"><A HREF="#002">PART II<BR> INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;3. Incorporation of Documents by Reference.</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#004">Item&nbsp;4. Description of Securities.</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#005">Item&nbsp;5. Interests of Named Experts and Counsel.</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#006">Item&nbsp;6. Indemnification of Directors and Officers.</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#007">Item&nbsp;7. Exemption From Registration Claimed.</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#008">Item&nbsp;8. Exhibits.</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#009">Item&nbsp;9. Undertakings</A></TD></TR>
  <TR><TD colspan="9"><A HREF="#010">SIGNATURES</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b55118s8exv5w1.htm">Ex-5.1 Opinion of Kirkpatrick & Lockhart Nicholson Graham LLP</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b55118s8exv23w1.htm">Ex-23.1 Consent of Ernst & Young LLP</A></TD></TR>
  </TABLE>
  </CENTER>
  <!-- /TOC -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  
  
  
  <!-- link1 "PART I<BR> INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS" -->
  <DIV align="left"><A NAME="000"></A></DIV>
  
  <P align="center" style="font-size: 10pt"><B>PART I<BR>
  INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS</B>
  
  
  <!-- link2 "Item&nbsp;1. Plan Information" -->
  <DIV align="left"><A NAME="001"></A></DIV>
  
  <P align="left" style="font-size: 10pt"><B>Item&nbsp;1. Plan Information</B>
  
  
  <P align="left" style="font-size: 10pt">Information required by this Part&nbsp;I, Item&nbsp;1 to be contained in the Section 10(a) prospectus is
  omitted from this Registration Statement in accordance with Rule&nbsp;428 under the Securities Act of
  1933, as amended, and the introductory Note to Part&nbsp;I of Form S-8.
  
  
  
  
  <P align="center" style="font-size: 10pt">&nbsp;
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  
  <!-- link1 "PART II<BR> INFORMATION REQUIRED IN THE REGISTRATION STATEMENT" -->
  <DIV align="left"><A NAME="002"></A></DIV>
  
  <P align="center" style="font-size: 10pt"><B>PART II<BR>
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
  
  
  <!-- link2 "Item&nbsp;3. Incorporation of Documents by Reference." -->
  <DIV align="left"><A NAME="003"></A></DIV>
  
  <P align="left" style="font-size: 10pt"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B>
  
  
  <P align="left" style="font-size: 10pt">The following documents of Cyberkinetics Neurotechnology Systems, Inc. (the &#147;Registrant&#148;), filed
  with the Securities and Exchange Commission (the &#147;Commission&#148;) are hereby incorporated by reference
  in this Registration Statement:
  
  
  
  <P>
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="5%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">&#149;&nbsp;&nbsp;</TD>
      <TD>Our Annual Report on Form 10-KSB for the fiscal year ended December&nbsp;31, 2004, as filed
  on March&nbsp;31, 2005 (including information specifically incorporated by reference into our
  10-KSB from our Proxy Statement for our 2005 Annual Meeting of Stockholders);</TD>
  </TR>
  
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="5%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">&#149;&nbsp;&nbsp;</TD>
      <TD>Our Quarterly Report on Form 10-QSB for the period ended
  March&nbsp;31, 2005, as filed on May&nbsp;13, 2005;</TD>
  </TR>
  
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="5%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">&#149;&nbsp;&nbsp;</TD>
      <TD>Our Current Reports on Form 8-K (other than information
  furnished pursuant to Item&nbsp;2.02 or Item&nbsp;9.01 thereof) as filed on January&nbsp;12, 2005, February&nbsp;1, 2005, March
  28, 2005, April&nbsp;4, 2005, April&nbsp;6, 2005, and April&nbsp;12,
  2005; and</TD>
  </TR>
  
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="5%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">&#149;&nbsp;&nbsp;</TD>
      <TD>The description of our common stock contained in our registration statement on Form
  SB-2, as filed on December&nbsp;3, 2004, including all amendments, reports and prospectus
  supplements filed for the purpose of updating such description.</TD>
  </TR>
  
  </TABLE>
  
  <P align="left" style="font-size: 10pt">We incorporate by reference the documents listed above and any documents subsequently filed with
  the SEC pursuant to Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the filing of
  a post-effective amendment to this registration statement, except for
  information furnished under Item&nbsp;2.02 or Item&nbsp;9.01 of
  Form&nbsp;8-K, which is not deemed filed and not incorporated by
  reference herein, which indicates that all securities
  offered have been sold or which deregisters all securities then remaining unsold, shall be deemed
  to be incorporated by reference in the Registration Statement and to be part thereof from the date
  of filing of such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein
  shall be deemed to be modified or superseded for purposes of this Registration Statement to the
  extent that a statement contained herein or in any subsequently filed document which also is deemed
  to be incorporated by reference herein modifies or supersedes such statement. Any such statement so
  modified or superseded shall not be deemed, except as so modified or superseded, to constitute a
  part of this Registration Statement.
  
  
  <!-- link2 "Item&nbsp;4. Description of Securities." -->
  <DIV align="left"><A NAME="004"></A></DIV>
  
  <P align="left" style="font-size: 10pt"><B>Item&nbsp;4. Description of Securities.</B>
  
  
  
  <P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
  
  <!-- link2 "Item&nbsp;5. Interests of Named Experts and Counsel." -->
  <DIV align="left"><A NAME="005"></A></DIV>
  
  <P align="left" style="font-size: 10pt"><B>Item&nbsp;5. Interests of Named Experts and Counsel.</B>
  
  
  
  <P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
  
  <!-- link2 "Item&nbsp;6. Indemnification of Directors and Officers." -->
  <DIV align="left"><A NAME="006"></A></DIV>
  
  <P align="left" style="font-size: 10pt"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B>
  
  
  <P align="left" style="font-size: 10pt">Under Section&nbsp;145 of the General Corporation Law of the State of Delaware, we can indemnify our
  directors and officers against liabilities they may incur in such capacities, including liabilities
  under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). Our Certificate of
  Incorporation provides that, pursuant to Delaware law, our directors shall not be liable for
  monetary damages for breach of the directors&#146; fiduciary duty of care to us and our stockholders.
  This provision in the certificate of incorporation does not eliminate the duty of care, and in
  appropriate circumstances equitable remedies such as injunctive or other forms of nonmonetary
  relief will remain available under Delaware law. In addition, each director will continue to be
  subject to liability for breach of the director&#146;s duty of loyalty to us or our stockholders, for
  acts or omissions not in good faith or involving intentional misconduct or knowing violations of
  the law, for actions leading to improper personal benefit to the director, and for payment of
  dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The
  provision also does not affect a director&#146;s responsibilities under any other law, such as the
  federal securities laws or state or federal environmental laws.
  
  
  
  <P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Bylaws provide for the indemnification of our directors to the fullest extent permitted by
  the Delaware General Corporation Law. Our Bylaws further provide that our Board of Directors has
  sole discretion to indemnify our officers and other employees. We may limit the extent of such
  indemnification by individual contracts with our
  
  
  <P align="center" style="font-size: 10pt">II-1
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  
  <P align="left" style="font-size: 10pt">directors and executive officers, but have not done so. We are required to advance, prior to the
  final disposition of any proceeding, promptly on request, all expenses incurred by any director or
  executive officer in connection with that proceeding on receipt of an undertaking by or on behalf
  of that director or executive officer to repay those amounts if it should be determined ultimately
  that he or she is not entitled to be indemnified under our Bylaws or otherwise. We are not,
  however, required to advance any expenses in connection with any proceeding if a determination is
  reasonably and promptly made by our Board of Directors by a majority vote of a quorum of
  disinterested Board members that (a)&nbsp;the party seeking an advance acted in bad faith or
  deliberately breached his or her duty to us or our stockholders and (b)&nbsp;as a result of such actions
  by the party seeking an advance, it is more likely than not that it will ultimately be determined
  that such party is not entitled to indemnification pursuant to the applicable sections of our
  Bylaws.
  
  <P align="left" style="font-size: 10pt">We also have directors&#146; and officers&#146; liability insurance.
  
  
  <!-- link2 "Item&nbsp;7. Exemption From Registration Claimed." -->
  <DIV align="left"><A NAME="007"></A></DIV>
  
  <P align="left" style="font-size: 10pt"><B>Item&nbsp;7. Exemption From Registration Claimed.</B>
  
  
  <P align="left" style="font-size: 10pt">Not applicable.
  
  
  <!-- link2 "Item&nbsp;8. Exhibits." -->
  <DIV align="left"><A NAME="008"></A></DIV>
  
  <P align="left" style="font-size: 10pt"><B>Item&nbsp;8. Exhibits.</B>
  
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="3%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="90%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">
      <TD nowrap align="left" colspan="3">Exhibit</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">
      <TD nowrap align="left" colspan="3" style="border-bottom: 1px solid #000000">Number</TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">4.1</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Second Amended and Restated 2002 Equity Incentive Plan, filed as Exhibit&nbsp;10.10
  to the Registrant&#146;s Quarterly Report on Form&nbsp;10-QSB for the quarter ended
  September&nbsp;30, 2004 and incorporated herein by reference.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">4.2</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Second Amended and Restated Founders&#146; Option Plan, filed as Exhibit&nbsp;10.11 to
  the Registrant&#146;s Quarterly Report on Form&nbsp;10-QSB for the quarter ended
  September&nbsp;30, 2004 and incorporated herein by reference.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">4.3</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of Incentive Stock Option Agreement, filed as Exhibit&nbsp;10.2 to the
  Registrant&#146;s Quarterly Report on Form&nbsp;10-QSB for the quarter ended March&nbsp;31,
  2005 and incorporated herein by reference.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">4.4</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of Non-Incentive Stock Option Agreement, filed as Exhibit&nbsp;10.3 to the
  Registrant&#146;s Quarterly Report on Form&nbsp;10-QSB for the quarter ended March&nbsp;31,
  2005 and incorporated herein by reference.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">5.1</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion of Kirkpatrick &#038; Lockhart Nicholson Graham LLP.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">23.1</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Ernst &#038; Young LLP.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">23.2</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Kirkpatrick &#038; Lockhart Nicholson Graham LLP (contained in Exhibit
  5.1).</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">24.1</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Power of Attorney (contained on signature page).</DIV></TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  <!-- link2 "Item&nbsp;9. Undertakings" -->
  <DIV align="left"><A NAME="009"></A></DIV>
  
  <P align="left" style="font-size: 10pt"><B>Item&nbsp;9. Undertakings</B>
  
  
  
  <P>
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="1%" nowrap align="left">(a)&nbsp;&nbsp;</TD>
      <TD>The Registrant hereby undertakes:</TD>
  </TR>
  
  </TABLE>
  
  
  <P>
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="5%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">(1)&nbsp;&nbsp;</TD>
      <TD>To file, during any period in which offers or sales are being made, a
  post-effective amendment to this Registration Statement</TD>
  </TR>
  
  </TABLE>
  
  
  <P>
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="10%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">(i)&nbsp;&nbsp;</TD>
      <TD>to include any prospectus required by Section&nbsp;10(a)(3) of the
  Securities Act of 1933;</TD>
  </TR>
  
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="10%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">(ii)&nbsp;&nbsp;</TD>
      <TD>to reflect in the prospectus any facts or events arising after
  the effective date of the registration statement (or the most recent
  post-effective amendment thereof) which, individually or in the aggregate,
  represent a fundamental change in the information set forth in the Registration
  Statement; and</TD>
  </TR>
  
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="10%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">(iii)&nbsp;&nbsp;</TD>
      <TD>to include any material information with respect to the plan
  of distribution not previously disclosed in the registration statement or any
  material change to such information in the Registration Statement;</TD>
  </TR>
  
  </TABLE>
  
  
  
  <P align="left" style="margin-left:10%; font-size: 10pt"><U>provided</U> <U>however</U>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not
  apply if the information required to be included in a post-effective amendment by
  those paragraphs is contained in periodic reports
  
  
  <P align="center" style="font-size: 10pt">II-2
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  <P align="left" style="margin-left:10%; font-size: 10pt">filed by the registrant pursuant to Sections&nbsp;13 or 15(d) of the Exchange Act of 1934
  that are incorporated by reference in the Registration Statement.
  
  
  <P>
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="5%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">(2)&nbsp;&nbsp;</TD>
      <TD>That, for the purpose of determining any liability under the Securities Act of
  1933, each such post-effective amendment shall be deemed to be a new registration
  statement relating to the securities offered therein, and the offering of such
  securities at that time shall be deemed to be the initial bona fide offering thereof.</TD>
  </TR>
  
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="5%" style="background: transparent">&nbsp;</TD>
      <TD width="4%" nowrap align="left">(3)&nbsp;&nbsp;</TD>
      <TD>To remove from registration by means of a post-effective amendment any of the
  securities being registered which remain unsold at the termination of the offering.</TD>
  </TR>
  
  </TABLE>
  
  
  <P>
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="1%" nowrap align="left">(b)&nbsp;&nbsp;</TD>
      <TD>The Registrant hereby undertakes, for the purposes of determining any liability under the
  Securities Act of 1933, each filing of the Registrant&#146;s Annual Report pursuant to Section
  13(a) or 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the
  registration statement shall be deemed to be a new registration statement relating to the
  securities offered therein, and the offering of such securities at that time shall be deemed
  to be the initial bona fide offering thereof.</TD>
  </TR>
  
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="1%" nowrap align="left">(c)&nbsp;&nbsp;</TD>
      <TD>Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
  permitted to directors, officers, and controlling persons of the registrant pursuant to the
  foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
  Securities and Exchange Commission such indemnification is against public policy as expressed
  in the Act and is, therefore, unenforceable. In the event that a claim for indemnification
  against such liabilities (other than the payment by the registrant of expenses incurred or
  paid by a director, officer or controlling person of the registrant in the successful defense
  of any action, suit or proceeding) is asserted by such director, officer or controlling person
  in connection with the securities being registered, the registrant will, unless in the opinion
  of its counsel the matter has been settled by controlling precedent, submit to a court of
  appropriate jurisdiction the question whether such indemnification by it is against public
  policy as expressed in the Act and will be governed by the final adjudication of such issue.</TD>
  </TR>
  
  </TABLE>
  
  <P align="center" style="font-size: 10pt">II-3
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  <P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  
  
  </TABLE>
  
  <!-- link1 "SIGNATURES" -->
  <DIV align="left"><A NAME="010"></A></DIV>
  
  <P align="center" style="font-size: 10pt"><B>SIGNATURES</B>
  
  
  <P align="left" style="font-size: 10pt">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has
  reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
  duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
  duly authorized, in the City of Foxborough, Massachusetts, on this 13&nbsp;day of May, 2005.
  
  
  
  <TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
  <TR>
      <TD width="48%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="35%">&nbsp;</TD>
      <TD width="15%">&nbsp;</TD>
  </TR>
  <TR>
      <TD valign="top" align="left">&nbsp;</TD>
      <TD colspan="3" align="left"><B>CYBERKINETICS NEUROTECHNOLOGY SYSTEMS, INC.</B><BR>
  &nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD valign="top">By:&nbsp;&nbsp;</TD>
      <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Timothy R. Surgenor
  &nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD colspan="2" align="left">Timothy R. Surgenor, President and Chief Executive Officer (Principal Executive&nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD colspan="2" align="left">Officer)&nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR>
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  </TABLE>
  
  <P align="center" style="font-size: 10pt"><B>POWER OF ATTORNEY</B>
  
  
  <P align="left" style="font-size: 10pt">We, the undersigned officers and directors of Cyberkinetics Neurotechnology Systems, Inc., do
  hereby constitute and appoint Timothy R. Surgenor or Kimi E. Iguchi, and each of them, as his or
  her true and lawful attorneys-in-fact and agents, with full power of substitution for him or her in
  any and all capacities, to sign any and all amendments (including post-effective amendments) to
  this Registration Statement, and to file the same, with all exhibits thereto, and other documents
  in connection therewith, with the Securities and Exchange Commission, granting unto said
  attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and
  every act and thing requisite and necessary to be done in connection therewith, as fully to all
  intents and purposes as he or she might or could do in person, hereby ratifying and confirming all
  that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or
  substitutes, may lawfully do or cause to be done by virtue hereof.
  
  
  <P align="left" style="font-size: 10pt">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been
  signed by the following persons in the capacities and on the dates indicated.
  
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="20%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="25%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="7%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">
      <TD nowrap align="center" style="border-bottom: 1px solid #000000">Names</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" style="border-bottom: 1px solid #000000">Title</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" style="border-bottom: 1px solid #000000">Date</TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Timothy R. Surgenor
  <HR size="1" noshade color="#000000">
  Timothy R. Surgenor</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  President, Chief Executive Officer
  and Director (Principal Executive
  Officer)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">May 13, 2005</TD>
  </TR>
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top">/s/ John P. Donoghue, Ph.D.
  <HR size="1" noshade color="#000000">
  John P. Donoghue, Ph.D.</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  Chief Scientific Officer and Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">May 13, 2005</TD>
  </TR>
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top">/s/ Kimi E. Iguchi
  <HR size="1" noshade color="#000000">
  Kimi E. Iguchi</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  Vice President, Finance
  (Principal Financial and Accounting
  Officer)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">May 13, 2005</TD>
  </TR>
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top">/s/ Mark P. Carthy
  <HR size="1" noshade color="#000000">
  Mark P. Carthy</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">May 13, 2005</TD>
  </TR>
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top">&nbsp;
  <HR size="1" noshade color="#000000">
  George N. Hatsopoulos, Ph.D.</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top">/s/ Nicholas G. Hatsopoulos, Ph.D.
  <HR size="1" noshade color="#000000">
  Nicholas G. Hatsopoulos, Ph.D.</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">May&nbsp;13, 2005</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <P align="center" style="font-size: 10pt">II-4
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="20%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="25%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="7%">&nbsp;</TD>
  </TR>
  
  <!-- Begin Table Body -->
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top">/s/ Philip W. Morgan
  <HR size="1" noshade color="#000000">
  Philip W. Morgan</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">May 13, 2005</TD>
  </TR>
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top">/s/ Theo Melas-Kyriazi
  <HR size="1" noshade color="#000000">
  Theo Melas-Kyriazi</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">May 13, 2005</TD>
  </TR>
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="left" nowrap valign="top">/s/ Daniel E. Geffken
  <HR size="1" noshade color="#000000">
  Daniel E. Geffken</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">May 13, 2005</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  
  <P align="center" style="font-size: 10pt">II-5
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  
  
  <P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>
  
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="3%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="90%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">
      <TD nowrap align="left" colspan="3">Exhibit</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">
      <TD nowrap align="left" colspan="3" style="border-bottom: 1px solid #000000">Number</TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">4.1</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Second Amended and Restated 2002 Equity Incentive Plan, filed as Exhibit&nbsp;10.10
  to the Registrant&#146;s Quarterly Report on Form&nbsp;10-QSB for the quarter ended
  September&nbsp;30, 2004 and incorporated herein by reference.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">4.2</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Second Amended and Restated Founders&#146; Option Plan, filed as Exhibit&nbsp;10.11 to
  the Registrant&#146;s Quarterly Report on Form&nbsp;10-QSB for the quarter ended
  September&nbsp;30, 2004 and incorporated herein by reference.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">4.3</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
  
  <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form
  of Incentive Stock Option Agreement, filed as Exhibit 10.2 to the Registrant&#146;s
  Quarterly Report on Form&nbsp;10-QSB for the quarter ended March&nbsp;31, 2005 and
  incorporated herein by reference.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">4.4</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
  
  <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form
  of Non-Incentive Stock Option Agreement, filed as Exhibit 10.3 to the Registrant&#146;s
  Quarterly Report on Form&nbsp;10-QSB for the quarter ended March&nbsp;31, 2005 and
  incorporated herein by reference.</DIV></TD>
  </TR>
  
  
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">5.1</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
  
  <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion
  of Kirkpatrick&nbsp;&#038; Lockhart Nicholson Graham LLP </DIV></TD>
  </TR>
  
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">23.1</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Ernst &#038; Young LLP.</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">23.2</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Kirkpatrick &#038; Lockhart Nicholson Graham LLP (contained in Exhibit
  5.1).</DIV></TD>
  </TR>
  <TR valign="bottom">
      <TD nowrap align="right" valign="top">&nbsp;</TD>
      <TD align="right" valign="top">24.1</TD>
      <TD nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Power of Attorney (contained on signature page).</DIV></TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  
  <P align="center" style="font-size: 10pt">&nbsp;
  </DIV>
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "b55118s8sv8.htm", "description": "CYBERKINETICS NEUROTECHNOLOGY SYSTEMS, INC.", "secsgml_size_bytes": 49123}]
metadata_filer: {"company-data": {"conformed-name": "Cyberkinetics Neurotechnology Systems, Inc.", "cik": "0001180253", "assigned-sic": "3841", "irs-number": "134287300", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-124928", "film-number": "05830001"}, "business-address": {"street1": "SUITE 240", "street2": "100 FOXBOROUGH BLVD.", "city": "FOXBOROUGH", "state": "MA", "zip": "02035", "phone": "508-549-9981"}, "mail-address": {"street1": "SUITE 240", "street2": "100 FOXBOROUGH BLVD.", "city": "FOXBOROUGH", "state": "MA", "zip": "02035"}, "former-company": {"former-conformed-name": "TRAFALGAR VENTURES INC", "date-changed": "20020814"}}
text: sv8
  Table of Contents
  As filed with the Securities and Exchange Commission on May 13, 2005
  Registration No. 333-_____
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM S-8
  Registration Statement Under The Securities Act of 1933
  CYBERKINETICS NEUROTECHNOLOGY SYSTEMS, INC.
  (Exact name of registrant as specified in its charter)
  Delaware
  13-4287300
  (State or other jurisdiction of
  incorporation or organization)
  (I.R.S. Employer
  Identification No.)
  100 Foxborough Blvd., Suite 240
  Foxborough, MA 02035
  (Address of principal
  executive offices)
  (508) 549-9981
  (Registrant's
  telephone number, including area code)
  Second Amended and Restated 2002 Equity Incentive Plan
  Second Amended and Restated Founders' Option Plan
  (Full Title of the
  plans)
  Timothy R. Surgenor
  President and Chief Executive Officer
  100 Foxborough Blvd., Suite 240
  Foxborough, MA 02035
  (508) 549-9981
  (Name, Address, and Telephone Number, Including Area Code, of Agent for Service)
  Copies to:
  Katherine J. Blair, Esq.
  Shoshannah D. Katz, Esq.
  Kirkpatrick & Lockhart Nicholson Graham LLP
  10100 Santa Monica Boulevard, Seventh Floor
  Los Angeles, CA 90067
  Telephone: (310) 552-5000
  Facsimile: (310) 552-5001
  CALCULATION OF REGISTRATION FEE
  Title of
  Proposed Maximum
  Proposed Maximum
  Securities to be
  Amount to be
  Offering Price
  Aggregate
  Amount of
  Registered
  Registered
  (1)
  per Share
  Offering Price
  Registration Fee
  Common Stock,
  $0.001 par value
  per share
  126,280 shares
  $
  1.55
  (2)
  $
  195,734
  (2)
  $
  23
  Common Stock,
  $0.001 par value
  per share
  3,413,150 shares
  $
  0.50
  (3)
  $
  1,706,575
  (3)
  $
  201
  Total:
  3,539,430 shares
  $
  1,902,309
  $
  224
  (1)
  Represents (i) 126,280 shares of Common Stock available for issuance under
  the Registrant's Second Amended and Restated 2002 Equity
  Incentive Plan, (ii) 2,344,735
  shares of Common Stock underlying outstanding stock options granted under the Registrant's
  Second Amended and Restated 2002 Equity Incentive Plan and
  (iii) 1,068,415 shares of Common
  Stock underlying stock options granted under the Registrant's Second Amended and Restated
  Founders' Option Plan. This Registration Statement also covers an indeterminate number of
  shares of Common Stock which may be issuable by reason of stock splits, stock dividends or
  similar transactions pursuant to Rule 416 of the Securities Act of 1933, as amended (the
  "Securities Act").
  (2)
  Estimated in accordance with Rule 457(c) and (h) under the Securities Act, solely
  for the purpose of calculating the total registration fee. Computation based upon the
  average of the high ($1.65) and low ($1.45) prices of the Common Stock as reported on the
  Over-the-Counter Bulletin Board on May 11, 2005.
  (3)
  Calculated solely for purposes of this offering under Rule 457(h) of the
  Securities Act on the basis of the weighted average exercise price of the outstanding
  options.
  TABLE OF CONTENTS
  PART I
  INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS
  Item 1. Plan Information
  PART II
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  Item 3. Incorporation of Documents by Reference.
  Item 4. Description of Securities.
  Item 5. Interests of Named Experts and Counsel.
  Item 6. Indemnification of Directors and Officers.
  Item 7. Exemption From Registration Claimed.
  Item 8. Exhibits.
  Item 9. Undertakings
  SIGNATURES
  Ex-5.1 Opinion of Kirkpatrick & Lockhart Nicholson Graham LLP
  Ex-23.1 Consent of Ernst & Young LLP
  Table of Contents
  PART I
  INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS
  Item 1. Plan Information
  Information required by this Part I, Item 1 to be contained in the Section 10(a) prospectus is
  omitted from this Registration Statement in accordance with Rule 428 under the Securities Act of
  1933, as amended, and the introductory Note to Part I of Form S-8.
  Table of Contents
  PART II
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  Item 3. Incorporation of Documents by Reference.
  The following documents of Cyberkinetics Neurotechnology Systems, Inc. (the "Registrant"), filed
  with the Securities and Exchange Commission (the "Commission") are hereby incorporated by reference
  in this Registration Statement:
  •
  Our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2004, as filed
  on March 31, 2005 (including information specifically incorporated by reference into our
  10-KSB from our Proxy Statement for our 2005 Annual Meeting of Stockholders);
  •
  Our Quarterly Report on Form 10-QSB for the period ended
  March 31, 2005, as filed on May 13, 2005;
  •
  Our Current Reports on Form 8-K (other than information
  furnished pursuant to Item 2.02 or Item 9.01 thereof) as filed on January 12, 2005, February 1, 2005, March
  28, 2005, April 4, 2005, April 6, 2005, and April 12,
  2005; and
  •
  The description of our common stock contained in our registration statement on Form
  SB-2, as filed on December 3, 2004, including all amendments, reports and prospectus
  supplements filed for the purpose of updating such description.
  We incorporate by reference the documents listed above and any documents subsequently filed with
  the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the filing of
  a post-effective amendment to this registration statement, except for
  information furnished under Item 2.02 or Item 9.01 of
  Form 8-K, which is not deemed filed and not incorporated by
  reference herein, which indicates that all securities
  offered have been sold or which deregisters all securities then remaining unsold, shall be deemed
  to be incorporated by reference in the Registration Statement and to be part thereof from the date
  of filing of such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein
  shall be deemed to be modified or superseded for purposes of this Registration Statement to the
  extent that a statement contained herein or in any subsequently filed document which also is deemed
  to be incorporated by reference herein modifies or supersedes such statement. Any such statement so
  modified or superseded shall not be deemed, except as so modified or superseded, to constitute a
  part of this Registration Statement.
  Item 4. Description of Securities.
  Not applicable.
  Item 5. Interests of Named Experts and Counsel.
  Not applicable.
  Item 6. Indemnification of Directors and Officers.
  Under Section 145 of the General Corporation Law of the State of Delaware, we can indemnify our
  directors and officers against liabilities they may incur in such capacities, including liabilities
  under the Securities Act of 1933, as amended (the "Securities Act"). Our Certificate of
  Incorporation provides that, pursuant to Delaware law, our directors shall not be liable for
  monetary damages for breach of the directors' fiduciary duty of care to us and our stockholders.
  This provision in the certificate of incorporation does not eliminate the duty of care, and in
  appropriate circumstances equitable remedies such as injunctive or other forms of nonmonetary
  relief will remain available under Delaware law. In addition, each director will continue to be
  subject to liability for breach of the director's duty of loyalty to us or our stockholders, for
  acts or omissions not in good faith or involving intentional misconduct or knowing violations of
  the law, for actions leading to improper personal benefit to the director, and for payment of
  dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The
  provision also does not affect a director's responsibilities under any other law, such as the
  federal securities laws or state or federal environmental laws.
  Our Bylaws provide for the indemnification of our directors to the fullest extent permitted by
  the Delaware General Corporation Law. Our Bylaws further provide that our Board of Directors has
  sole discretion to indemnify our officers and other employees. We may limit the extent of such
  indemnification by individual contracts with our
  II-1
  Table of Contents
  directors and executive officers, but have not done so. We are required to advance, prior to the
  final disposition of any proceeding, promptly on request, all expenses incurred by any director or
  executive officer in connection with that proceeding on receipt of an undertaking by or on behalf
  of that director or executive officer to repay those amounts if it should be determined ultimately
  that he or she is not entitled to be indemnified under our Bylaws or otherwise. We are not,
  however, required to advance any expenses in connection with any proceeding if a determination is
  reasonably and promptly made by our Board of Directors by a majority vote of a quorum of
  disinterested Board members that (a) the party seeking an advance acted in bad faith or
  deliberately breached his or her duty to us or our stockholders and (b) as a result of such actions
  by the party seeking an advance, it is more likely than not that it will ultimately be determined
  that such party is not entitled to indemnification pursuant to the applicable sections of our
  Bylaws.
  We also have directors' and officers' liability insurance.
  Item 7. Exemption From Registration Claimed.
  Not applicable.
  Item 8. Exhibits.
  Exhibit
  Number
  4.1
  Second Amended and Restated 2002 Equity Incentive Plan, filed as Exhibit 10.10
  to the Registrant's Quarterly Report on Form 10-QSB for the quarter ended
  September 30, 2004 and incorporated herein by reference.
  4.2
  Second Amended and Restated Founders' Option Plan, filed as Exhibit 10.11 to
  the Registrant's Quarterly Report on Form 10-QSB for the quarter ended
  September 30, 2004 and incorporated herein by reference.
  4.3
  Form of Incentive Stock Option Agreement, filed as Exhibit 10.2 to the
  Registrant's Quarterly Report on Form 10-QSB for the quarter ended March 31,
  2005 and incorporated herein by reference.
  4.4
  Form of Non-Incentive Stock Option Agreement, filed as Exhibit 10.3 to the
  Registrant's Quarterly Report on Form 10-QSB for the quarter ended March 31,
  2005 and incorporated herein by reference.
  5.1
  Opinion of Kirkpatrick & Lockhart Nicholson Graham LLP.
  23.1
  Consent of Ernst & Young LLP.
  23.2
  Consent of Kirkpatrick & Lockhart Nicholson Graham LLP (contained in Exhibit
  5.1).
  24.1
  Power of Attorney (contained on signature page).
  Item 9. Undertakings
  (a)
  The Registrant hereby undertakes:
  (1)
  To file, during any period in which offers or sales are being made, a
  post-effective amendment to this Registration Statement
  (i)
  to include any prospectus required by Section 10(a)(3) of the
  Securities Act of 1933;
  (ii)
  to reflect in the prospectus any facts or events arising after
  the effective date of the registration statement (or the most recent
  post-effective amendment thereof) which, individually or in the aggregate,
  represent a fundamental change in the information set forth in the Registration
  Statement; and
  (iii)
  to include any material information with respect to the plan
  of distribution not previously disclosed in the registration statement or any
  material change to such information in the Registration Statement;
  provided
  however
  , that paragraphs (a)(1)(i) and (a)(1)(ii) do not
  apply if the information required to be included in a post-effective amendment by
  those paragraphs is contained in periodic reports
  II-2
  Table of Contents
  filed by the registrant pursuant to Sections 13 or 15(d) of the Exchange Act of 1934
  that are incorporated by reference in the Registration Statement.
  (2)
  That, for the purpose of determining any liability under the Securities Act of
  1933, each such post-effective amendment shall be deemed to be a new registration
  statement relating to the securities offered therein, and the offering of such
  securities at that time shall be deemed to be the initial bona fide offering thereof.
  (3)
  To remove from registration by means of a post-effective amendment any of the
  securities being registered which remain unsold at the termination of the offering.
  (b)
  The Registrant hereby undertakes, for the purposes of determining any liability under the
  Securities Act of 1933, each filing of the Registrant's Annual Report pursuant to Section
  13(a) or 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the
  registration statement shall be deemed to be a new registration statement relating to the
  securities offered therein, and the offering of such securities at that time shall be deemed
  to be the initial bona fide offering thereof.
  (c)
  Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
  permitted to directors, officers, and controlling persons of the registrant pursuant to the
  foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
  Securities and Exchange Commission such indemnification is against public policy as expressed
  in the Act and is, therefore, unenforceable. In the event that a claim for indemnification
  against such liabilities (other than the payment by the registrant of expenses incurred or
  paid by a director, officer or controlling person of the registrant in the successful defense
  of any action, suit or proceeding) is asserted by such director, officer or controlling person
  in connection with the securities being registered, the registrant will, unless in the opinion
  of its counsel the matter has been settled by controlling precedent, submit to a court of
  appropriate jurisdiction the question whether such indemnification by it is against public
  policy as expressed in the Act and will be governed by the final adjudication of such issue.
  II-3
  Table of Contents
  SIGNATURES
  Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has
  reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
  duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
  duly authorized, in the City of Foxborough, Massachusetts, on this 13 day of May, 2005.
  CYBERKINETICS NEUROTECHNOLOGY SYSTEMS, INC.
  By:
  /s/ Timothy R. Surgenor
  Timothy R. Surgenor, President and Chief Executive Officer (Principal Executive
  Officer)
  POWER OF ATTORNEY
  We, the undersigned officers and directors of Cyberkinetics Neurotechnology Systems, Inc., do
  hereby constitute and appoint Timothy R. Surgenor or Kimi E. Iguchi, and each of them, as his or
  her true and lawful attorneys-in-fact and agents, with full power of substitution for him or her in
  any and all capacities, to sign any and all amendments (including post-effective amendments) to
  this Registration Statement, and to file the same, with all exhibits thereto, and other documents
  in connection therewith, with the Securities and Exchange Commission, granting unto said
  attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and
  every act and thing requisite and necessary to be done in connection therewith, as fully to all
  intents and purposes as he or she might or could do in person, hereby ratifying and confirming all
  that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or
  substitutes, may lawfully do or cause to be done by virtue hereof.
  Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been
  signed by the following persons in the capacities and on the dates indicated.
  Names
  Title
  Date
  /s/ Timothy R. Surgenor
  Timothy R. Surgenor
  President, Chief Executive Officer
  and Director (Principal Executive
  Officer)
  May 13, 2005
  /s/ John P. Donoghue, Ph.D.
  John P. Donoghue, Ph.D.
  Chief Scientific Officer and Director
  May 13, 2005
  /s/ Kimi E. Iguchi
  Kimi E. Iguchi
  Vice President, Finance
  (Principal Financial and Accounting
  Officer)
  May 13, 2005
  /s/ Mark P. Carthy
  Mark P. Carthy
  Director
  May 13, 2005
  George N. Hatsopoulos, Ph.D.
  Director
  /s/ Nicholas G. Hatsopoulos, Ph.D.
  Nicholas G. Hatsopoulos, Ph.D.
  Director
  May 13, 2005
  II-4
  Table of Contents
  /s/ Philip W. Morgan
  Philip W. Morgan
  Director
  May 13, 2005
  /s/ Theo Melas-Kyriazi
  Theo Melas-Kyriazi
  Director
  May 13, 2005
  /s/ Daniel E. Geffken
  Daniel E. Geffken
  Director
  May 13, 2005
  II-5
  Table of Contents
  EXHIBIT INDEX
  Exhibit
  Number
  4.1
  Second Amended and Restated 2002 Equity Incentive Plan, filed as Exhibit 10.10
  to the Registrant's Quarterly Report on Form 10-QSB for the quarter ended
  September 30, 2004 and incorporated herein by reference.
  4.2
  Second Amended and Restated Founders' Option Plan, filed as Exhibit 10.11 to
  the Registrant's Quarterly Report on Form 10-QSB for the quarter ended
  September 30, 2004 and incorporated herein by reference.
  4.3
  Form
  of Incentive Stock Option Agreement, filed as Exhibit 10.2 to the Registrant's
  Quarterly Report on Form 10-QSB for the quarter ended March 31, 2005 and
  incorporated herein by reference.
  4.4
  Form
  of Non-Incentive Stock Option Agreement, filed as Exhibit 10.3 to the Registrant's
  Quarterly Report on Form 10-QSB for the quarter ended March 31, 2005 and
  incorporated herein by reference.
  5.1
  Opinion
  of Kirkpatrick & Lockhart Nicholson Graham LLP
  23.1
  Consent of Ernst & Young LLP.
  23.2
  Consent of Kirkpatrick & Lockhart Nicholson Graham LLP (contained in Exhibit
  5.1).
  24.1
  Power of Attorney (contained on signature page).